This gene is thought to play an important role in calciumhomeostasis. Alternative splicing of this gene results in five transcript variants which vary in protein translation, the coding of catalytic domains, and tissue expression. Variation among these transcripts impacts their functions which involve roles in the calcium storage and release process in the endoplasmic and sarcoplasmic reticulum as well as hydroxylation of aspartic acid and asparagine in epidermal growth factor-like domains of various proteins.[3]
Mutations in ASPH cause Traboulsi syndrome.Patel, N; Khan, A. O.; Mansour, A; Mohamed, J. Y.; Al-Assiri, A; Haddad, R; Jia, X; Xiong, Y; Mégarbané, A; Traboulsi, E. I.; Alkuraya, F. S. (2014). "Mutations in ASPH Cause Facial Dysmorphism, Lens Dislocation, Anterior-Segment Abnormalities, and Spontaneous Filtering Blebs, or Traboulsi Syndrome". The American Journal of Human Genetics. 94 (5): 755–9. doi:10.1016/j.ajhg.2014.04.002. PMID24768550.
References
↑Korioth F, Gieffers C, Frey J (Feb 1995). "Cloning and characterization of the human gene encoding aspartyl beta-hydroxylase". Gene. 150 (2): 395–9. doi:10.1016/0378-1119(94)90460-X. PMID7821814.
↑Ince N, de la Monte SM, Wands JR (March 2000). "Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation". Cancer Res. 60 (5): 1261–6. PMID10728685.
↑ 5.05.1Xue T, Xue XP, Huang QS, Wei L, Sun K, Xue T (August 2009). "Monoclonal antibodies against human aspartyl (asparaginyl) beta-hydroxylase developed by DNA immunization". Hybridoma (Larchmt). 28 (4): 251–7. doi:10.1089/hyb.2009.0017. PMID19663697.
↑ 6.06.1Palumbo KS, Wands JR, Safran H, King T, Carlson RI, de la Monte SM (July 2002). "Human aspartyl (asparaginyl) beta-hydroxylase monoclonal antibodies: potential biomarkers for pancreatic carcinoma". Pancreas. 25 (1): 39–44. doi:10.1097/00006676-200207000-00010. PMID12131769.
↑Hampton T (November 2007). "New screening techniques show potential for early detection of lung cancer". JAMA. 298 (17): 1997. doi:10.1001/jama.298.17.1997. PMID17986689.
Zhang L, Kelley J, Schmeisser G, et al. (1997). "Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane". J. Biol. Chem. 272 (37): 23389–97. doi:10.1074/jbc.272.37.23389. PMID9287354.
Wetzel GT, Ding S, Chen F (2000). "Molecular cloning of junctin from human and developing rabbit heart". Mol. Genet. Metab. 69 (3): 252–8. doi:10.1006/mgme.2000.2966. PMID10767180.
Dinchuk JE, Henderson NL, Burn TC, et al. (2001). "Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin". J. Biol. Chem. 275 (50): 39543–54. doi:10.1074/jbc.M006753200. PMID10956665.
Treves S, Feriotto G, Moccagatta L, et al. (2001). "Molecular cloning, expression, functional characterization, chromosomal localization, and gene structure of junctate, a novel integral calcium binding protein of sarco(endo)plasmic reticulum membrane". J. Biol. Chem. 275 (50): 39555–68. doi:10.1074/jbc.M005473200. PMID11007777.
Kirchhefer U, Neumann J, Baba HA, et al. (2001). "Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1". J. Biol. Chem. 276 (6): 4142–9. doi:10.1074/jbc.M006443200. PMID11069905.
Sepe PS, Lahousse SA, Gemelli B, et al. (2002). "Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility". Lab. Invest. 82 (7): 881–91. doi:10.1097/01.lab.0000020406.91689.7f. PMID12118090.
Ho SP, Scully MS, Krauthauser CM, et al. (2002). "Antisense oligonucleotides selectively regulate aspartyl beta-hydroxylase and its truncated protein isoform in vitro but distribute poorly into A549 tumors in vivo". J. Pharmacol. Exp. Ther. 302 (2): 795–803. doi:10.1124/jpet.302.2.795. PMID12130746.
Xian ZH, Zhang SH, Cong WM, et al. (2006). "Expression of aspartyl beta-hydroxylase and its clinicopathological significance in hepatocellular carcinoma". Mod. Pathol. 19 (2): 280–6. doi:10.1038/modpathol.3800530. PMID16341145.
de la Monte SM, Tamaki S, Cantarini MC, et al. (2006). "Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness". J. Hepatol. 44 (5): 971–83. doi:10.1016/j.jhep.2006.01.038. PMID16564107.
Feldmann G, Nattermann J, Nischalke HD, et al. (2006). "Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer". Endoscopy. 38 (6): 604–9. doi:10.1055/s-2006-925065. PMID16673309.
Gundogan F, Elwood G, Greco D, et al. (2007). "Role of aspartyl-(asparaginyl) beta-hydroxylase in placental implantation: Relevance to early pregnancy loss". Hum. Pathol. 38 (1): 50–9. doi:10.1016/j.humpath.2006.06.005. PMID16949909.